Relapse

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, accounting for approximately 30% of all cases....

The Role of Allogeneic Hematopoietic Stem-Cell Transplantation in Treating Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Scientific Report Introduction: Diffuse...

A Study on the Use of Post-Transplant Cyclophosphamide in Third HLA-Haploidentical Stem Cell Transplantation for Relapsed Acute Leukemia Introduction: Acute...

Phase Ia Trial in Solid Tumours Initiated by Nuvectis Pharma: A Promising Step Towards Advanced Cancer Treatment Nuvectis Pharma, a...

Forma Medical Introduces OptimalHT: The First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure, a Breakthrough in Medical Technology Hammertoe, a common...

Title: The Factors Behind the Higher Cost of 5-Star Luxury Rehab: Assessing its Value Introduction: Luxury rehab centers have gained...

The U.S. Food and Drug Administration (FDA) has recently granted orphan drug designation to Faron Pharmaceuticals’ experimental drug, Bexmarilimab, for...

Targeting Pyruvate Anaplerosis: A Potential Vulnerability in Persistent Leukemic Stem Cells – A Study in Nature Communications Leukemia, a type...

A Real-World Analysis of Abatacept for Preventing Graft Versus Host Disease in Pediatric Patients Receiving 7/8 HLA-Mismatched Unrelated Transplants for...

The Role of Postmortem-derived iPSC Models in Advancing Substance Use Disorders Research in Neuropsychopharmacology Substance use disorders (SUDs) are a...

A Comparative Analysis of GVHD Prophylaxis Methods in 10/10 HLA-Matched Unrelated Allogeneic Hematopoietic Cell Transplantation: Evaluating Post-Transplant Cyclophosphamide versus Antithymocyte...

Insights from Synergy Research Center San Diego: Discover Effective Strategies for Managing Anxiety Anxiety is a common mental health condition...

Affect, a leading digital therapeutics company focused on addiction treatment, has recently announced securing $16 million in funding. This funding...